Reversal effect of resveratrol on multidrug resistance in KBv200 cell line

Biomedicine and Pharmacotherapy

Volumn 62, Issue 9, 2008, Pages 622-629

  Quan, Fang ^a   Pan, Chengen ^a   Ma, Qingyong ^a   Zhang, Shaoqiang ^a   Yan, Liying ^a  

^a First Affiliated Hospital   (China)

Author keywords

Apoptosis; Human oral epidermoid carcinoma KB cell; Multidrug resistance; Resveratrol

Indexed keywords

DOXORUBICIN; PACLITAXEL; RESVERATROL; VERAPAMIL; VINCRISTINE;

APOPTOSIS; ARTICLE; BCL 2 GENE; CANCER CELL CULTURE; CELL CLONE; CONTROLLED STUDY; CROSS RESISTANCE; DRUG EFFECT; DRUG MECHANISM; GENE; GENE EXPRESSION; HUMAN; HUMAN CELL; MDR1 GENE; MULTIDRUG RESISTANCE; PRIORITY JOURNAL; PROTEIN EXPRESSION; SQUAMOUS CELL CARCINOMA;

ANTINEOPLASTIC AGENTS, PHYTOGENIC; APOPTOSIS; CELL LINE, TUMOR; DRUG RESISTANCE, MULTIPLE; DRUG RESISTANCE, NEOPLASM; HUMANS; P-GLYCOPROTEIN; PROTO-ONCOGENE PROTEINS C-BCL-2; STILBENES; VINCRISTINE;

EID: 54049147251     PISSN: 07533322     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.biopha.2008.07.089     Document Type: Article

References (36)

1. Ambudkar S.V., Dey S., Hrycyna C.A., Ramachandra M., Pastan I., and Gottesman M.M. Biochemical, cellular, and pharmacological aspects of the multidrug transporter. Annu Rev Pharmacol Toxicol 39 (1999) 361-398
2. Callaghan R., Ford R.C., and Kerr I.D. The translocation mechanism of P-glycoprotein. FEBS Lett 580 (2006) 1056-1063
3. Litman T., Druley T.E., Stein W.D., and Bates S.E. From MDR to MXR: new understanding of multidrug resistance systems, their properties and clinical significance. Cell Mol Life Sci 58 (2001) 931-959
4. Gottesman M.M. Mechanisms of cancer drug resistance. Annu Rev Med 53 (2002) 615-627
5. Ushigome F., Takanaga H., Matsuo H., Yanai S., Tsukimori K., Nakano H., et al. Human placental transport of vinblastine, vincristine, digoxin and progesterone: contribution of P-glycoprotein. Eur J Pharmacol 408 (2000) 1-10
6. Choi C.H. ABC transporters as multidrug resistance mechanisms and the development of chemosensitizers for their reversal. Cancer Cell Int 5 (2005) 30
7. Marbeuf-Gueye C., Salerno M., Quidu P., and Garnier-Suillerot A. Inhibition of the P-glycoprotein- and multidrug resistance protein-mediated efflux of anthracyclines and calcein acetoxymethyl ester by PAK-104P. Eur J Pharmacol 391 (2000) 207-216
8. Hsu P.-C., Hun H.-C., Liao Y.-F., Liu C.-C., Gregory J.T., and Liu G.-Y. Ornithine decarboxylase attenuates leukemic chemotherapy drugs-induced cell apoptosis and arrest in human promyelocytic HL-60 cells. Leuk Res 32 (2008) 1530-1540
9. Hockenberry D., Nunez G., Milliman C., McDonnell T.J., Platt F.M., London L., et al. Bcl-2 is an inner mitochondrial membrane protein that blocks programmed cell death. Nature 348 (1990) 334-336
10. Motomura M., Min Kwon K., Suh S.-J., Lee Y.-C., Kim Y.-K., Lee I.-S., et al. Propolis induces cell cycle arrest and apoptosis in human leukemic U937 cells through Bcl-2/Bax regulation. Environ Toxicol Pharmacol 26 (2008) 61-67
11. Manion M.K., Fry J., Schwartz P.S., and Hockenbery D.M. Small-molecule inhibitors of Bcl-2. Curr Opin Investig Drugs 7 (2006) 1077-1084
12. Teodori E., Dei S., Martelli C., Scapecchi S., and Gualtieri F. The functions and structure of ABC transporters: implications for the design of new inhibitors of P-glycoprotein and MRP1 to control multidrug resistance (MDR). Curr Drug Targets 7 (2006) 893-909
13. Di Pietro A., Conseil G., Pérez-Victoria J.M., Dayan G., Baubichon-Cortay H., Trompier D., et al. Modulation by flavonoids of cell multidrug resistance mediated by P-glycoprotein and related ABC transporters. Cell Mol Life Sci 59 (2002) 307-322
14. Chearwaw W., Anuchapreeda S., Nandigama K., Ambudkar S.V., and Limtrakul P. Biochemical mechanism of modulation of human P-glycoprotein (ABCB1) by curcumin I, II, and III purified from turmeric powder. Biochem Pharmacol 68 (2004) 2043-2052
15. Kitagawa S. Inhibitory effects of polyphenols on P-glycoprotein-mediated transport. Biol Pharm Bull 29 (2006) 1-6
16. Borowski E., Bontemps-Gracz M.M., and Piwkowska A. Strategies for overcoming ABC-transporters-mediated multidrug resistance (MDR) of tumor cells. Acta Biochim Pol 52 (2005) 609-627
17. Nonomura S., Kanagawa H., Makimoto A., Slowing K.V., Thomas C.F., and Beecher C.W. Chemical constituents of polygonaceous plants. I. Studies on the components of Ko-jokon (Polygonum cuspidatum SIEB et ZUCC). Yakugaku Zasshi 83 (1963) 983-988
18. Jang M., Cai L., Udeani G.O., Slowing K.V., Thomas C.F., Beecher C.W., et al. Cancer chemopreventive activity of resveratrol, a natural product derived from grapes. Science 275 (1997) 218-220
19. Richard J.L. Coronary risk factors. The French paradox. Arch Mal Coeur Vaiss 80 (1987) 17-21
20. Renaud S., and de Lorgeril M. Wine, alcohol, platelets, and the French paradox for coronary heart disease. Lancet 339 (1992) 1523-1526
21. Criqui M.H., and Ringel B.L. Does diet or alcohol explain the French paradox?. Lancet 344 (1994) 1719-1723
22. Langcake P., and Pryce R.J. The production of resveratrol by Vitis vinifera and other members of the Vitaceae as a response to infection or injury. Physiol Plant Pathol 9 (1976) 77-86
23. Siemann E.H., and Creasy L.L. Concentration of the phytoalexin resveratrol in wine. Am J Enol Vitic 43 (1992) 49-52
24. Ferguson L.R. Role of plant polyphenols in genomic stability. Mutat Res 475 (2001) 89-111
25. Middleton E.J., Kandaswami C., and Theoharides T.C. The effects of plant flavonoids on mammalian cells: implications for inflammation, heart disease, and cancer. Pharmacol Rev 52 (2000) 673-751
26. Sun C., Hu Y., Liu X., Wu T., Wang Y., He W., et al. Resveratrol downregulates the constitutional activation of nuclear factor-kappa B in multiple myeloma cells, leading to suppression of proliferation and invasion, arrest of cell cycle, and induction of apoptosis. Cancer Genet Cytogenet 165 (2006) 9-19
27. Liu H., Liu Q., and Zhang H. Effect of resveratrol combined with chemotherapeutic agent on mouse hepatoma carcinoma cell line in vivo and in vitro. Chinese Journal of Experimental Surgery 21 (2004) 230
28. Wang X.H., Jia D.Z., Liang Y.J., Yan S.L., Ding Y., Chen L.M., et al. Lgf-YL-9 induces apoptosis in human epidermoid carcinoma KB cells and multidrug resistant KBv200 cells via reactive oxygen species-independent mitochondrial pathway. Cancer Lett 249 (2007) 256-270
29. V200. Cancer Lett 119 (1997) 177-184
30. V200 cells by MDR1 antisense RNA. Biochem Biophys Res Commun 239 (1997) 345-348
31. Fu L.W., Liang Y.J., Deng L.W., Chen L.M., Ruan J.W., Ding Y., et al. A potent inhibitor of P-glycoprotein-mediated multidrug resistance. Cancer Chemother Pharmacol 53 (2004) 349-356
32. Qu X.J., Yang J.L., and Russell P.J. Changes in epidermal growth factor receptor expression in human bladder cancer cell lines following interferon-alpha treatment. J Urol 172 (2004) 733-738
33. Jain S., Laphookhieo S., Shi Z., et al. Reversal of P-glycoprotein mediated multidrug resistance by sipholane triterpenoids. J Nat Prod 70 (2007) 928-931
34. Labeed F.H., Coley H.M., Thomas H., and Hughes M.P. Assessment of multidrug resistance reversal using dielectrophoresis and flow cytometry. Biophys J 85 (2003) 2028-2034
35. Sheng L., and An L.F. Research on resveratrol's effects of suppressing growth and inducing apoptosis of GBC cells. J Chin Med Mater 28 (2005) 489-491
36. Yu H., Pan C., Zhao S., Wang Z., Zhang H., and Wu W. Resveratrol inhibits tumor necrosis factor-a mediated matrix metalloproteinase-9 expression and invasion of human hepatocellular carcinoma cells. Biomed Pharmacother 62 (2008) 366-372